Thackray Helen M. is Chief R&D Officer of Biocryst Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ImmunoGen, Inc.
12 Feb 24
4
ImmunoGen, Inc.
3 Jan 24
4
BIOCRYST PHARMACEUTICALS INC
20 Dec 23
4
BIOCRYST PHARMACEUTICALS INC
18 Dec 23
4
ImmunoGen, Inc.
2 Oct 23
4
ImmunoGen, Inc.
5 Jul 23
4
ImmunoGen, Inc.
16 Jun 23
4
BIOCRYST PHARMACEUTICALS INC
5 Apr 23
4
ImmunoGen, Inc.
4 Apr 23
4
BIOCRYST PHARMACEUTICALS INC
21 Dec 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Feb 24 | IMGN Immunogen | Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,074 | 0.00 | 0 |
12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 17.72 | 19,597 | 347.26 k | 0 |
12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.37 | 32,066 | 108.06 k | 0 |
12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.97 | 44,000 | 262.68 k | 0 |
12 Feb 24 | IMGN Immunogen | Deferred Share Unit Common Stock | Sale back to company | Dispose D | No | No | 0 | 40,932 | 0.00 | 0 |
12 Feb 24 | IMGN Immunogen | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 13,090 | 0.00 | 0 |
29 Dec 23 | IMGN Immunogen | Common Stock | Grant | Acquire A | No | No | 29.65 | 252 | 7.47 k | 3,074 |
19 Dec 23 | BCRX Biocryst Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 6.05 | 5,580 | 33.76 k | 249,664 |
14 Dec 23 | BCRX Biocryst Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 6.43 | 3,031 | 19.49 k | 255,244 |
14 Dec 23 | BCRX Biocryst Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 51,000 | 0.00 | 258,275 |